Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06212323 · ClinicalTrials.gov registry record
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
A clinical trial of Smoldering Multiple Myeloma, sponsored by University of Utah.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06212323 is a study of Smoldering Multiple Myeloma that is actively recruiting participants, run by University of Utah. The registered enrollment target is 100 participants, below the 795-participant average among 20 other Smoldering Multiple Myeloma trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06212323, a study of Smoldering Multiple Myeloma, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to define the natural history of high-risk smoldering myeloma in a modern cohort of patients undergoing close standard of care follow-up with diffusion weighted whole body magnetic resonance imaging.
Conditions Studied
Interventions
- OTHER Patients with smoldering myeloma undergoing active surveillance with diffusion weighted whole body MRI.
Study Locations (1)
Utah
- Huntsman Cancer Institute at the University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-11 |
| Est. Completion | 2030-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06212323
The ClinicalTrials.gov registry entry for NCT06212323 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 795-participant average among 20 other Smoldering Multiple Myeloma trials with a reported enrollment target (87% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoldering Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which Patients with smoldering myeloma undergoing active surveillance with diffusion weighted whole body MRI. is the first listed.
NCT06212323 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06212323 about?
NCT06212323 is a clinical study titled "Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial". The purpose of this study is to define the natural history of high-risk smoldering myeloma in a modern cohort of patients undergoing close standard of care follow-up with diffusion weighted whole body magnetic resonance imaging.
What is the current status of trial NCT06212323?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-01-11. Estimated completion is 2030-03.
What conditions does trial NCT06212323 study?
This clinical trial studies the following conditions: Smoldering Multiple Myeloma.
What interventions are being tested in trial NCT06212323?
The interventions under investigation include: Patients with smoldering myeloma undergoing active surveillance with diffusion weighted whole body MRI. (OTHER).
Who is sponsoring clinical trial NCT06212323?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06212323 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoldering Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
RECRUITING · Phase 2
-
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
RECRUITING
-
Registry for Adults With Plasma Cell Disorders (PCD's)
RECRUITING
-
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
RECRUITING · Phase 2
-
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
RECRUITING · NA
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.